Approval · Notice of Compliance 6522 · 1996
TRI-IMMUNOL: Notice of Compliance 6522
Issued May 3, 1996
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 6522
- Date
- May 3, 1996
- Company
- Wyeth-Ayerst Canada Inc.St. Laurent, Quebec, Canada
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Change in the manufacturer's name
- Therapeutic class
- Active immunizing agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TRI-IMMUNOL | 02019981 | Cancelled Post Market |
Medicinal ingredients
- DIPHTHERIA TOXOID 12.5 LF per 0.5ML
- TETANUS TOXOID 5 LF per 0.5ML
- PERTUSSIS VACCINE 4 UNIT per 0.5ML